Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under general anaesthetic
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Intensity-modulated radiotherapy
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Oncology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	288	1368
Performance Status recorded	85%	78%
PSA completed	88%	82%
Gleason Score completed	78%	81%
TNM completed	90%	78%
Multiparametric MRI performed	79%	80%
At least 1 treatment modality recorded	87%	93%

	Specialist MDT	National
No. of men with disease status determined	1277	39295
Percentage of men diagnosed with metastatic disease	16%	16%

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	103	2581
Percentage of men with low-risk localised disease receiving radical treatment	3%	4%
No. of men diagnosed with locally advanced disease	505	15573
Percentage of men diagnosed with locally advanced disease receiving radical treatment	68%	68%
No. of men with high risk/locally advanced prostate cancer who received radiotherapy	214	6974
Percentage of men having radical radiotherapy for high-risk/locally advanced disease receiving a brachytherapy boost	14%	5%
No. of men diagnosed with N+ M0 (node positive, no metastases)	43	1821
Percentage of men diagnosed with N+ M0 (node positive, no metastases) receiving docetaxel	9%	14%
No. of men diagnosed with M1 (metastases)	204	6085
Percentage of men diagnosed with M1 (metastases) receiving docetaxel	28%	27%

	Diagnosing Trust	National
No. of men diagnosed with intermediate-risk disease	41	3457
Percentage of men diagnosed with intermediate-risk disease receiving a hypofractionated regimen	97%	91%
No. of men diagnosed with high-risk disease	68	6966
Percentage of men diagnosed with high-risk disease receiving a hypofractionated regimen	73%	59%

	Treatment Centre
No. of men who received radical prostatectomy (2017-2018)	51
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	17%
No. of men who received radical prostatectomy (2016)	38
Adjusted percentage of men experiencing at least one GU complication (%)	6%
No. of men who received radical radiotherapy (2016)	111
Adjusted percentage of men experiencing at least one GI complication (%)	14%